Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the…
Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins Regulatory approval from the U.K. and…
SYDNEY, July 22, 2022 /PRNewswire/ – Recently, Jinko Solar Australia Holding Co PTY. LTD., one of the largest and most innovative…
MELBOURNE, Australia, July 22, 2022 /PRNewswire/ – As a key part of its global tour, VisionNav debuts its iconic autonomous forklift…
– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive…
SYDNEY and NEW SOUTH WALES, Australia, July 21, 2022 /PRNewswire/ — Binance Australia Derivatives has launched over-the-counter (OTC) derivative products,…
MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly…
MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Airwallex, a leading global fintech platform, announced the launch of its Airwallex Online…
New advisory board members will help solar steam leader meet the soaring demand for industrial decarbonization NEW YORK, July 21,…
SYDNEY, July 20, 2022 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address…
